Central Bank & Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Central Bank & Trust’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15	Closed	-$417	–	352
2023 Q3	$417	Hold	15	–	–	﹤0.01%	331
2023 Q2	$511	Hold	15	–	–	﹤0.01%	322
2023 Q1	$450	Hold	15	–	–	﹤0.01%	410
2022 Q4	$423	Buy	+15	New	+$476	﹤0.01%	333

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Central Bank & Trust's ARKG Position: Q4 2023 in Review

Central Bank & Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 15 shares — an estimated $417 sold.

Central Bank & Trust first reported a position in ARKG in Q4 2022 and held it in 4 quarters. The position peaked at $511 in Q2 2023. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

Central Bank & Trust reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
Central Bank & Trust sold 15 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $417.
Central Bank & Trust first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 4 quarters.
Central Bank & Trust's ARK Genomic Revolution ETF position peaked at $511 in Q2 2023.
298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Central Bank & Trust's 13F filing for Q4 2023, filed 9 Jan 2024.